サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1536137

先進ドラッグデリバリーシステムの世界市場

Advanced Drug Delivery Systems

出版日
ページ情報
英文 283 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
先進ドラッグデリバリーシステムの世界市場
出版日: 2024年08月16日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 283 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

先進ドラッグデリバリーシステムの世界市場は2030年までに3,624億米ドルに達する見込み

2023年に2,511億米ドルと推定された先進ドラッグデリバリーシステムの世界市場は、分析期間2023-2030年にCAGR 5.4%で成長し、2030年には3,624億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経口ドラッグデリバリーは、CAGR 6.2%を記録し、分析期間終了時には1,583億米ドルに達すると予測されます。肺ドラッグデリバリーセグメントの成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は684億米ドルと推定、中国はCAGR 8.9％で成長予測

米国の先進ドラッグデリバリーシステム市場は2023年に684億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに765億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1%と5.5%と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の先進ドラッグデリバリーシステム市場- 主要動向と促進要因まとめ

先進ドラッグデリバリーシステム（ADDS）には、医薬品化合物の投与と有効性を高める幅広い技術が含まれます。これらのシステムは、副作用を最小限に抑えながら、薬剤を疾患部位に特異的に標的化し、薬剤放出速度を制御し、治療作用の持続時間を延長するように設計されています。ADDSの主な種類には、リポソーム、ナノ粒子、経皮パッチ、埋め込み型デバイスなどがあります。例えば、ナノ粒子は組織の深部まで浸透して細胞レベルに直接薬剤を送達することができ、経皮パッチは皮膚から長期間にわたって薬剤を放出します。このような標的を絞ったアプローチは、薬剤が必要な場所に正確に作用することで患者の予後を改善するだけでなく、必要な全体量を減らすことで毒性の可能性を減らすことにもつながります。

このようなシステムの開発は、材料科学、バイオテクノロジー、ナノテクノロジーにおける最新の進歩に大きな影響を受けています。研究者たちは、身体と安全に相互作用し、特定の生物学的トリガーに反応して薬物を放出することができる新しい材料を絶えず探求しています。例えば、あらかじめ決められた速度で溶解する生分解性ポリマーは、薬剤溶出ステントやインプラントの製造に使用されています。ナノテクノロジーの面では、デンドリマー（高度に分岐した星形の高分子）が、がんや感染症などの問題に効果的に対処するために、薬物や標的分子を付着させる有望なフレームワークを提供しています。薬剤レベルや患者の健康マーカーをリアルタイムでモニターするセンサーなど、ADDSへのスマート技術の統合も増加しています。こうした技術革新は、リアルタイムのデータに基づいて患者一人ひとりのニーズに合わせて治療を行う、より個別化された医療の実践につながっています。

先進ドラッグデリバリーシステム市場の成長は、慢性疾患の負担増、より効率的で利便性の高い治療オプションに対する需要の高まり、医薬品研究開発への多額の投資など、いくつかの要因によって牽引されています。糖尿病、がん、心血管疾患などの慢性疾患の流行は、長期にわたる複雑な治療レジメンを必要とすることが多いため、治療プロトコルを簡素化し、アドヒアランスを改善できる、より効果的なデリバリーシステムが必要とされています。さらに、個別化医療の推進により、個々の患者の要求に適応可能なドラッグデリバリーシステムに対する需要が高まっています。より高度で低侵襲な送達オプションの開拓を可能にする技術の進歩も、この市場の拡大に寄与しています。さらに、予防ヘルスケアへの消費者行動の変化や、家庭用自動注射器などの治療の自己投与の受け入れ拡大が、ADDSの成長をさらに促進しています。このような要因が重なることで、先進ドラッグデリバリーシステムは、世界のヘルスケアに大きな影響を与える可能性を秘めた、ダイナミックで急速に進化する分野となるのです。

調査対象企業の例（全86件）

  • Becton, Dickinson and Company
  • Cadence Inc.
  • Croda Pharma
  • DCA Design International Limited
  • Enable Injections, Inc.
  • Evonik Health Care
  • Gerresheimer AG
  • Kindeva Drug Delivery
  • Medmix Ltd.
  • SHL Medical AG
  • Sparsha Pharma International Pvt Ltd
  • SPI Pharma
  • SteriPack Group
  • Stevanato Group
  • Ypsomed AG;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26655

Global Advanced Drug Delivery Systems Market to Reach US$362.4 Billion by 2030

The global market for Advanced Drug Delivery Systems estimated at US$251.1 Billion in the year 2023, is expected to reach US$362.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Oral Drug Delivery, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$158.3 Billion by the end of the analysis period. Growth in the Pulmonary Drug Delivery segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$68.4 Billion While China is Forecast to Grow at 8.9% CAGR

The Advanced Drug Delivery Systems market in the U.S. is estimated at US$68.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$76.5 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Advanced Drug Delivery Systems Market - Key Trends and Drivers Summarized

Advanced drug delivery systems (ADDS) encompass a broad range of technologies that enhance the administration and efficacy of pharmaceutical compounds. These systems are designed to target drugs specifically to disease sites, control the rate of drug release, and increase the duration of therapeutic action, all while minimizing side effects. Key types of ADDS include liposomes, nanoparticles, transdermal patches, and implantable devices. Each system has its own unique mechanism of action: for instance, nanoparticles can penetrate deep into tissues to deliver drugs directly to the cellular level, while transdermal patches release medication through the skin over an extended period. This targeted approach not only improves patient outcomes by ensuring that the drug acts precisely where it is needed but also reduces the overall dosage required, thereby decreasing the potential for toxicity.

The development of these systems is heavily influenced by the latest advances in materials science, biotechnology, and nanotechnology. Researchers are continually exploring new materials that can safely interact with the body and respond to specific biological triggers to release drugs. For example, biodegradable polymers that dissolve at pre-determined rates are used to fabricate drug-eluting stents and implants. On the nanotechnology front, dendrimers — highly branched, star-shaped macromolecules — offer promising frameworks for attaching drugs and targeting molecules to address issues like cancer and infectious diseases effectively. The integration of smart technology into ADDS, such as sensors that monitor drug levels and patient health markers in real time, is also on the rise. These innovations are leading to more personalized medicine practices, where treatments can be tailored to the individual needs of each patient based on real-time data.

The growth in the advanced drug delivery systems market is driven by several factors, including the increasing burden of chronic diseases, the rising demand for more efficient and convenient therapeutic options, and significant investments in pharmaceutical R&D. The prevalence of chronic conditions like diabetes, cancer, and cardiovascular diseases, which require prolonged and often complex treatment regimens, has led to a need for more effective delivery systems that can simplify treatment protocols and improve adherence. Moreover, the push towards personalized medicine is increasing the demand for drug delivery systems that are adaptable to individual patient requirements. Technological advancements that enable the development of more sophisticated and minimally invasive delivery options also contribute to the expansion of this market. Additionally, the consumer behavior shift towards preventive healthcare and the growing acceptance of self-administration of treatments, such as auto-injectors for home use, are further catalyzing the growth of ADDS. The convergence of these factors ensures that advanced drug delivery systems continue to represent a dynamic and rapidly evolving field with significant potential for impacting global healthcare practices.

Select Competitors (Total 86 Featured) -

  • Becton, Dickinson and Company
  • Cadence Inc.
  • Croda Pharma
  • DCA Design International Limited
  • Enable Injections, Inc.
  • Evonik Health Care
  • Gerresheimer AG
  • Kindeva Drug Delivery
  • Medmix Ltd.
  • SHL Medical AG
  • Sparsha Pharma International Pvt Ltd
  • SPI Pharma
  • SteriPack Group
  • Stevanato Group
  • Ypsomed AG;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Advanced Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Nanotechnology Innovations Propel Development of Advanced Drug Delivery Systems
    • Rising Prevalence of Chronic Diseases Expands Addressable Market for Targeted Delivery Solutions
    • Patient-Centric Drug Development Trends Bolster Adoption of User-Friendly Drug Delivery Technologies
    • Expansion of Home Healthcare Market Sets the Stage for Ambulatory and Self-Administered Drug Delivery
    • Technological Breakthroughs in 3D Printing of Drug Delivery Devices Generate Market Opportunities
    • Global Diabetes Epidemic Spurs Development of Advanced Insulin Delivery Systems
    • Evolving Oncology Treatments Require Novel Drug Delivery Approaches
    • Shift Toward Non-Invasive Delivery Methods Spurs Product Innovation
    • Technological Integration in Drug Delivery Devices Fuels Development of Connected Medical Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Advanced Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Advanced Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pulmonary Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pulmonary Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pulmonary Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Parenteral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Parenteral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Parenteral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Pulmonary Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Pulmonary Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Pulmonary Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • JAPAN
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • CHINA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • EUROPE
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Advanced Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • FRANCE
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • GERMANY
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • INDIA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Advanced Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Advanced Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • AFRICA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030

IV. COMPETITION